Liver and intrahepatic bile ducts-nontumor
Familial apolipoprotein A-I amyloidosis
Reviewers: Komal Arora, M.D. (see Reviewers page)
Revised: 24 April 2012, last major update April 2012
Copyright: (c) 2004-2012, PathologyOutlines.com, Inc.
● Apo A-I is major protein constituent of plasma high density lipoprotein; is synthesized in liver and intestine
● At least 10 different amyloidogenic Apo A-I mutations exist
● Liver transplant slows disease progression
● Case reports of 2 sisters with liver transplants (Mod Pathol 2001;14:577)
● Often striking liver parenchymal involvement by large patches of amyloid replacing hepatic lobules, separating hepatic cords, accentuation around central veins, involving portal triads, hilar soft tissue
● No involvement of hilar nerve branches or vagus nerve
Extensive amyloid deposition
Congo red stain
● Congo red
● Amyloid 2003;10:215, J Mol Diagn 2009;11:257
End of Liver and intrahepatic bile ducts-nontumor > Metabolic diseases > Familial apolipoprotein A-I amyloidosis
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).